Inspire Medical Systems, Inc. (INSP) vs Mineralys Therapeutics, Inc. (MLYS)

A side-by-side comparison of Inspire Medical Systems, Inc. and Mineralys Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INSP vs MLYS

growth of $100 · dividends reinvested · last 4y
INSP -73.6% (-28.3%/yr)MLYS +26.4% (+6.0%/yr)MLYS compounded faster over this window
050100150200250Start $100202420252026$26$126
INSP MLYS

INSP vs MLYS: by the numbers

  • •MLYS is the larger company ($2.01B vs $2.01B market cap).
  • •INSP is profitable (15.03% net margin) while MLYS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricINSPMLYS
P/E ratio15.02N/A
Forward P/E58.12N/A
P/S ratio2.23N/A
P/B ratio2.433.65
EV / EBITDA26.75N/A
FCF yield5.84%N/A

Profitability

MetricINSPMLYS
Gross margin86.13%0.00%
Operating margin6.02%0.00%
Net margin15.03%0.00%
ROE16.36%-63.45%
ROIC6.33%-57.17%

Growth (annualized)

MetricINSPMLYS
Revenue CAGR (5Y)38.69%N/A
Total return CAGR (5Y)-21.38%N/A

Frequently asked

Is INSP or MLYS more profitable?
INSP runs the higher net margin — INSP at 15.03% versus MLYS at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.